Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Receptor, ErbB-2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22CK%22&type=Subject&filter%5B%5D=topic_facet%3A%22Receptor%2C+ErbB-2%22
/vufind/Search/Results?lookfor=%22CK%22&type=Subject&filter%5B%5D=topic_facet%3A%22Receptor%2C+ErbB-2%22
Search /vufind/Search2/Results?lookfor=%22CK%22&type=Subject&filter%5B%5D=topic_facet%3A%22Receptor%2C+ErbB-2%22
PubPharm (5.727)
1
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer : recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines
enthalten in:
Breast cancer (Tokyo, Japan)
| 2024
von
Hattori, M.
|
Honma, N.
|
Nagai, S.
| +18
Wird geladen...
2
A Multifunctional Bimetallic Nanoplatform for Synergic Local Hyperthermia and Chemotherapy Targeting HER2-Positive Breast Cancer
enthalten in:
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
| 2024
von
Zhao, L.
|
Chang, F.
|
Tong, Y.
| +5
Wird geladen...
3
Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast Cancers
enthalten in:
Monoclonal antibodies in immunodiagnosis and immunotherapy
| 2024
von
Kaneko, M.
|
Suzuki, H.
|
Kato, Y.
ErratumIn: Monoclon Antib Immunodiagn Immunother. 2024 Apr 16;:. - PMID 38625004
Wird geladen...
4
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain) : a randomised, open-label, phase 2 trial
enthalten in:
Lancet (London, England)
| 2024
von
Pérez-García, J.
|
Cortés, J.
|
Ruiz-Borrego, M.
| +27
Wird geladen...
5
Safe de-escalation of chemotherapy in HER2-positive early breast cancer
enthalten in:
Lancet (London, England)
| 2024
von
Earl, H.
Wird geladen...
6
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
enthalten in:
The Lancet. Oncology
| 2024
von
Smit, E.
|
Felip, E.
|
Uprety, D.
| +17
Wird geladen...
7
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
enthalten in:
Anticancer research
| 2024
von
Sato, M.
|
Han, Q.
|
Mori, R.
| +7
Wird geladen...
8
Fe3O4-Cy5.5-trastuzumab magnetic nanoparticles for magnetic resonance/near-infrared imaging targeting HER2 in breast cancer
enthalten in:
Biomedical materials (Bristol, England)
| 2024
von
Yin, Q.
|
Gao, X.
|
Zhang, H.
| +5
Wird geladen...
9
Chinese expert consensus on the management of clinical pathway and adverse events of trastuzumab deruxtecan (2024 edition)
enthalten in:
Zhonghua zhong liu za zhi [Chinese journal of oncology
| 2024
von
Trastuzumab Deruxtecan Clinical Management Pathway and Adverse Reaction Management Consensus Expert Group
Wird geladen...
10
NSABP FB-10 : a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
enthalten in:
Breast cancer research : BCR
| 2024
von
Jacobs, S.
|
Wang, Y.
|
Abraham, J.
| +18
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[573]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Receptor, ErbB-2
Medienart
5.727
Aufsätze
4.657
E-Artikel
4.657
E-Ressourcen
1.070
Gedruckte Aufsätze
Zeitschriftentitel
268
Breast cancer research and treatment
216
Journal of clinical oncology : official journal...
185
Clinical cancer research : an official journal ...
169
Annals of oncology : official journal of the Eu...
115
Breast (Edinburgh, Scotland)
112
Clinical breast cancer
110
Gan to kagaku ryoho. Cancer & chemotherapy
93
The Lancet. Oncology
89
The oncologist
88
British journal of cancer
79
BMC cancer
79
PloS one
78
Cancer research
69
Scientific reports
68
Anticancer research
68
Journal of the National Cancer Institute
67
European journal of cancer (Oxford, England : 1...
65
Oncotarget
63
Breast cancer research : BCR
63
Cancer chemotherapy and pharmacology
Alle anzeigen ...
weniger ...
Thema
5.727
EC 2.7.10.1
Receptor, ErbB-2
5.706
P188ANX8CK
5.706
Trastuzumab
5.321
Journal Article
3.428
Antibodies, Monoclonal, Humanized
2.690
ERBB2 protein, human
2.285
Research Support, Non-U.S. Gov't
2.080
Antineoplastic Agents
1.871
Antibodies, Monoclonal
879
Review
606
Biomarkers, Tumor
567
Lapatinib
555
0VUA21238F
553
Multicenter Study
545
Quinazolines
528
pertuzumab
514
Antineoplastic Agents, Immunological
510
K16AIQ8CTM
507
Research Support, N.I.H., Extramural
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.321
2020-
2.976
2010-2019
994
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.357
Englisch
142
Japanisch
71
Französisch
66
Chinesisch
30
Deutsch
11
Russisch
9
Ungarisch
8
Italienisch
6
Polnisch
6
Spanisch
5
Tschechisch
4
Niederländisch
4
Portugiesisch
3
Hebräisch
1
Dänisch
1
Finnisch
1
Schwedisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...